Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

58.30
Delayed Data
As of 3:59pm ET
 -0.17 / -0.29%
Today’s Change
39.65
Today|||52-Week Range
63.40
+4.89%
Year-to-Date
Minerva On Track to Initiate Phase III Schizophrenia Study
10:17am / Zacks.com - Paid Partner Content
Alkermes Commences Phase III Study for Schizophrenia Drug
Jun 12 / Zacks.com - Paid Partner Content